Immunovant (IMVT) Q1 2025 Earnings

6FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.76
-0.65
-0.54
-0.43

Details

Expected EPS
-0.751667
Actual EPS
-0.76
Surprise EPS
-0.01
Surprise Percent
+1.11%

Description

Immunovant (IMVT) has reported earnings of -0.76 per share for Q1 2025.

0 Comments

Share your thoughts